C. Theocharopoulos

发表

An overview of antibody–drug conjugates in oncological practice

H. Gogas, D. Ziogas, C. Theocharopoulos, 2020, Therapeutic advances in medical oncology.

Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?

H. Gogas, J. Haanen, D. Ziogas, 2022, Cancer treatment reviews.

Neuromuscular Complications of Targeted Anticancer Agents: Can Tyrosine Kinase Inhibitors Induce Myasthenia Gravis? Getting Answers From a Case Report up to a Systematic Review

P. Ascierto, H. Gogas, D. Ziogas, 2021, Frontiers in Oncology.

Beyond CTLA-4 and PD-1 Inhibition: Novel Immune Checkpoint Molecules for Melanoma Treatment

H. Gogas, D. Ziogas, C. Theocharopoulos, 2023, Cancers.

Antibody-Drug Conjugates: Functional Principles and Applications in Oncology and Beyond

H. Gogas, D. Ziogas, M. Samarkos, 2021, Vaccines.

Using playback theatre to address the stigma of mental disorders

C. Theocharopoulos, L. Yotis, C. Fragiadaki, 2017 .

Systems and Causal Loop Thinking in Medicine: From Healthcare Delivery to Healthcare Policy Making

C. Theocharopoulos, 2020 .

Polymorphisms in CLEC5A and CLEC7A genes modify risk for inflammatory bowel disease

M. Gazouli, E. Legaki, Tilemachos Koutouratsas, 2023, Annals of gastroenterology.

Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic Depiction

K. Koutsoukos, M. Liontos, S. Sakellariou, 2023, Cancers.

New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3

Amalia Anastasopoulou, C. Theocharopoulos, Dimitra Foteinou, 2024, Vaccines.

Antibody-drug conjugates for hepato-pancreato-biliary malignancies: "Magic bullets" to the rescue?

C. Theocharopoulos, Ioannis A Ziogas, Charalampos-Christos Douligeris, 2024, Cancer treatment reviews.